Comparison of Effects of Statin Use on Mortality in Patients With Peripheral Arterial Disease With Versus Without Elevated C-Reactive Protein and D-Dimer Levels

American Journal of Cardiology

Volumn 105, Issue 9, 2010, Pages 1348-1352

  Vidula, Himabindu ^a   Tian, Lu ^b   Liu, Kiang ^a   Criqui, Michael H ^c   Ferrucci, Luigi ^d   Guralnik, Jack M ^d   Green, David ^a   Ridker, Paul ^e   McDermott, Mary M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; D DIMER; STATIN;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; COMPARATIVE STUDY; CONFOUNDING VARIABLE; CONTROLLED STUDY; DRUG EFFECT; DRUG USE; FEMALE; FOLLOW UP; GENDER; HAZARD RATIO; HUMAN; LEG ARTERY; MALE; MORTALITY; PRIORITY JOURNAL; RACE;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAUSE OF DEATH; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FOLLOW-UP STUDIES; HUMANS; LEG; MALE; PERIPHERAL VASCULAR DISEASES; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIBIAL ARTERIES; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER; UNITED STATES;

EID: 77950832723     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.12.054     Document Type: Article

References (22)

1. McDermott M.M., Green D., Greenland P., Liu K., Criqui M.H., Chan C., Guralnik J.M., Pearce W.H., Ridker P.M., Taylor L., Rifai N., and Schneider J.R. Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. Am J Cardiol 92 (2003) 194-199
2. McDermott M.M., Guralnik J.M., Corsi A., Albay M., Macchi C., Bandinelli S., and Ferrucci L. Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study. Am Heart J 150 (2005) 276-281
3. McDermott M.M., Liu K., Greenland P., Guralnik J.M., Criqui M.H., Chan C., Pearce W.H., Schneider J.R., Ferrucci L., Celic L., Taylor L.M., Vonesh E., Martin G.J., and Clark E. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA 292 (2004) 453-461
4. McDermott M.M., Hoff F., Ferrucci L., Pearce W.H., Guralnik J.M., Tian L., Liu K., Schneider J.R., Sharma L., Tan J., and Criqui M.H. Lower extremity ischemia, calf skeletal muscle characteristics, and functional impairment in peripheral arterial disease. J Am Geriatr Soc 55 (2007) 400-406
5. Newman A.B., Siscovick D.S., Manolio T.A., Polak J., Fried L.P., Borhani N.O., and Wolfson S.K. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation 88 (1993) 837-845
6. McDermott M.M., Criqui M.H., Liu K., Guralnik J.M., Greenland P., Martin G.J., and Pearce W. The lower ankle brachial index calculated by averaging the dorsalis pedis and posterior tibial arterial pressures is most closely associated with leg functioning in peripheral arterial disease. J Vasc Surg 32 (2000) 1164-1171
7. Hiatt W.R., Hoag S., and Hamman R.F. Effect of diagnostic criteria on the prevalence of peripheral arterial disease: the San Luis valley diabetes study. Circulation 91 (1995) 1472-1479
8. Shadman R., Criqui M.H., Bundens W.P., Fronek A., Denenberg J.O., Gamst A.C., and McDermott M.M. Subclavian artery stenosis: prevalence, risk factors, and association with cardiovascular disease. J Am Coll Cardiol 44 (2004) 618-623
9. Guralnik J.M., Fried L.P., Simonsick E.M., Kasper J.D., and Lafferty M.E. The Women's Health and Aging Study: health and social characteristics of older women with disability. NIH Publication Number 95-4009, Appendix E (1995), National Institute on Aging, Bethesda, MD
10. Ledue T.B., Weiner D.L., Sipe J.D., Poulin S.E., Collins M.F., and Rifai N. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A, and mannose binding protein in human serum. Ann Clin Biochem 35 (1998) 745-753
11. Allain C.C., Poon L.S., Chan C.S., Richmond W., and Fu P.C. Enzymatic determination of total serum cholesterol. Clin Chem 20 (1974) 470-475
12. Sugiuchi H., Ugi Y., Okabe H., Irie T., Uekama K., Nayahara N., and Miyauchi K. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated a-cyclodextrin. Clin Chem 41 (1995) 717-723
13. Ridker P.M., Danielson E., Fonseca F.A., Genest J., Gotto A.M., Kastelein J.J.P., Keonig W., Libby P., Lorenzatti A.J., MacFayden J.G., Nordestgaard B.G., Shepherd J., Willerson J.T., Glynn R.J., and JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359 (2008) 2195-2207
14. Vidula H., Tian L., Liu K., Criqui M.H., Ferrucci L., Pearce W.H., Greenland P., Green D., Tan J., Garside D.B., Guralnik J., Ridker P.M., Rifai N., and McDermott M.M. Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study. Ann Intern Med 148 (2008) 85-93
15. Fuster V., and Lewis A. Conner memorial lecture: mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 90 (1994) 2126-2146
16. Stary H.C., Chandler A.B., Dinsmore R.E., Fuster V., Glagov S., Insull Jr. W., Rosenfeld M.E., Schwartz C.J., Wagner W.D., and Wissler R.W. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92 (1995) 1355-1374
17. Takemoto M., and Liao J.K. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol 21 (2001) 1712-1719
18. Blanco-Colio L.M., Tuñón J., Martín-Ventura J.L., and Egido J. Anti-inflammatory and immunomodulatory effects of statins. Kidney Int 63 (2003) 12-23
19. Blann A.D., Gurney D., Hughes E., Buggins P., Silverman S.H., and Lip G.Y. Influence of pravastatin on lipoproteins, and on endothelial, platelet, and inflammatory markers in subjects with peripheral artery disease. Am J Cardiol 88 (2001) A7-A8 89-92
20. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
21. Schillinger M., Exner M., Mlekusch W., Amighi J., Sabeti S., Muellner M., Rumpold H., Wagner O., and Minar E. Statin therapy improves cardiovascular outcome of patients with peripheral artery disease. Eur Heart J 25 (2004) 742-748
22. Schillinger M., Exner M., Mlekusch W., Haumer M., Ahmadi R., Rumpold H., Wagner O., and Minar E. Balloon angioplasty and stent implantation induce a vascular inflammatory reaction. J Endovasc Ther 9 (2002) 59-66